Search

… company dedicated to changing lives through transformative RNA therapies, today announced it has again successfully … filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in …

… Officer role, with leadership oversight of Axiomer ® RNA-editing platform technology John Maraganore, PhD, former …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … 10 (LCA10). Presentation title :  Proof-of-concept for RNA-editing oligonucleotide QR-110 for treatment of inherited …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: ○   Proof-of-concept …

… (SAB).  In vivo proof of concept data for novel Axiomer ®  RNA editing platform technology presented at the OTS meeting and …

… A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology Key Updates Dr. Peter A. Beal joins … of RNA-based therapeutics, particularly in the area of RNA editing. As an expert in the field of ADAR and A-to-I …

… ProQR is accelerating the development of its Axiomer ® RNA base-editing technology platform across multiple therapeutic areas …

… QR-313 was granted ODD in the U.S. and Europe. Axiomer ® RNA-editing technology was introduced at the Company’s second …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … November 20 at 1:20-2:00 p.m. GMT Presentation at the 1 st RNA Editing Summit During the 1 st RNA Editing Summit to be held …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … advisory board. "Dr. Yu is a pioneer of targeted RNA editing to correct protein translation defects caused by …